Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Mickey Fulp: Buy the Unknown, Unloved, Unwanted, Undervalued

Maurice Jackson: Joining us for conversation is Mickey Fulp, the world-renowned Mercenary Geologist . I want to speak to you today about the mainstream financial news networks and the narratives that they're pushing on both sides of the aisle, respectively. And of cou...

Feb 28th 2020, Silver Chartbook – The weakest link

The weakest link The weakest link is you . That is not always easy to admit, but it is factual, that the main cause for large draw downs is human error. The list of errors in market participation is long. For example running stops or sitting frozen behind the monitor ...

Buzz on the Bullboards: When will the bear awaken?

2023 has started off with a bang for investors, as many sectors continue to adjust to rising inflation. It has been an up-and-down week for Canadian markets so far, but there seems to be an upbeat sentiment from markets across the globe. Many expect the Federal Reserv...

Cassava Sciences' Shares Trade Up 20% on Updated Phase 2a Alzheimer's Data

Shares of Cassava Sciences traded 20% higher after the firm presented additional data from the Phase 2a study of its investigational drug candidate PTI-125 for Alzheimer's disease to the Clinical Trials on Alzheimer's Disease conference in San Diego, Calif. Neurodegen...

Cassava Shares Rise on Updated Phase 2b Alzheimer's Drug Trial Data

Shares of Cassava Sciences traded 70% higher after the firm provided updates from its Phase 2b study of PTI-125 for use in treating Alzheimer' disease. Clinical-stage biotechnology company Cassava Sciences Inc. (SAVA:NASDAQ) , which focuses on neurodegenerative di...

June 26th 2020, Silver Chartbook – Silver let it ride

Silver let it ride Time relativity errors occur typically after long established sideways ranges. Meaning you get out too early of your trade. You waited a long time to finally be in your desired trade and even though everything goes perfect you want out really badly. The...

Gilead Drug May Cure COVID-19 But Won’t Save the Markets

Big news out today on CNBC about Gilead drug cured all 125 people from serious COVID-19 conditions within 5 days, This is amazing to hear, stocks are popping today up 3-5% which is to be expected for this type of news but the damage to the financial markets has already been ...

Surprise decision in the UK to thwart a No-Deal Brexit changed the dynamics of the markets

Our August 19 th prediction of a market breakdown, as well as our continued research suggesting a breakdown in price was the most likely outcome, is a combination of technical analysis, predictive modeling and our understanding of the market dynamics at play throughout the wo...

The Equities Wedge At The Edge – Front And Center

We continue to alert our followers of the extended Wedge (Flag or Pennant) formation that has setup over the past 16+ months in most of the US major indexes. The reason these are so important for skilled technical traders is because the Apex of these formations typically resul...

Soliton Shares Rise on Announcement It Will Report Clinical Data at National Dermatology Conference

Soliton Inc. shares traded 10% higher today after advising that later this month it will present the data from clinical trials for its Rapid Acoustic Pulse device used in the treatment of keloid and hypertrophic scars at the American Society for Dermatologic Surgery Annual Mee...
1 2 3